Page 14 - ZEA Flipbook

Optionality to Mitigate Risk

Competitively advantaged in the biotech industry

Human
Drug Platform Financing
Capital

• Multiple programs; one going to • Follow on financing can cover • Use of multiple consulting firms
IND in approximately 18 months up to 2 drug programs accelerates drug timeframe

• Platform covers many disease • Ability to financially partner with • Can scale human capital as
categories multiple strategic companies needed for each drug program